The company also anticipates releasing its Ilizerov Type Fixator System in the next quarter, pending FDA clearance. The company’s goal is to offer value priced, high quality orthopedic implants.
More Articles on Orthopedic Implants:
BioMimetic Reports Revenue Increase in 2011 to $1.7B
17 Spine Devices Receive FDA 510(k) Clearance in February
New Test Will Fight Infection in Hip, Knee Replacements
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.